Literature DB >> 8165182

The physicochemical properties, plasma enzymatic hydrolysis, and nasal absorption of acyclovir and its 2'-ester prodrugs.

Z Shao1, G B Park, R Krishnamoorthy, A K Mitra.   

Abstract

A series of 2'-(O-acyl) derivatives of 9-(2-hydroxyethoxymethyl)guanine (acyclovir) was synthesized by acid anhydride esterification. Aqueous solubilities in isotonic phosphate buffer (pH 7.4), partition coefficients in 1-octanol/phosphate buffer, and hydrolysis kinetics in rat plasma were determined. The ester prodrugs showed consistent increases in lipophilicity with corresponding decreases in aqueous solubility as a function of side-chain length. The bioconversion kinetics of the prodrugs appear to depend on both the apolar and the steric nature of the acyl substituents. When perfused through the rat nasal cavity using the in situ perfusion technique, acyclovir showed no measurable loss from the perfusate. Nasal uptake of acyclovir prodrugs, on the other hand, were moderately improved. Furthermore, the extent of nasal absorption appears to depend on the lipophilicity of the prodrugs in the descending order hexanoate > valerate > pivalate > butyrate. Simultaneous prodrug cleavage by nasal carboxylesterase was also noted in the case of hexanoate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8165182     DOI: 10.1023/a:1018903407592

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  The molecular weight dependence of nasal absorption: the effect of absorption enhancers.

Authors:  M D Donovan; G L Flynn; G L Amidon
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Drug metabolism in the nasal mucosa.

Authors:  M A Sarkar
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

3.  Drug absorption through mucosal membranes: effect of mucosal route and penetrant hydrophilicity.

Authors:  D C Corbo; J C Liu; Y W Chien
Journal:  Pharm Res       Date:  1989-10       Impact factor: 4.200

4.  Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs.

Authors:  Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

5.  Studies on the promoting effects of medium chain fatty acid salts on the nasal absorption of insulin in rats.

Authors:  M Mishima; Y Wakita; M Nakano
Journal:  J Pharmacobiodyn       Date:  1987-11

6.  Synthesis and antiviral activity of 9-alkoxypurines. 1. 9-(3-Hydroxypropoxy)- and 9-[3-hydroxymethyl)propoxy]purines.

Authors:  M R Harnden; P G Wyatt; M R Boyd; D Sutton
Journal:  J Med Chem       Date:  1990-01       Impact factor: 7.446

7.  Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations.

Authors:  Z Shao; R Krishnamoorthy; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

8.  Nasal membrane and intracellular protein and enzyme release by bile salts and bile salt-fatty acid mixed micelles: correlation with facilitated drug transport.

Authors:  Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

9.  Enhanced delivery of 5-iodo-2'-deoxyuridine to the brain parenchyma.

Authors:  M K Ghosh; A K Mitra
Journal:  Pharm Res       Date:  1992-09       Impact factor: 4.200

10.  Acyclovir permeation enhancement across intestinal and nasal mucosae by bile salt-acylcarnitine mixed micelles.

Authors:  G B Park; Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

View more
  7 in total

1.  In vivo evaluation of acyclovir prodrug penetration and metabolism through rat skin using a diffusion/bioconversion model.

Authors:  H Bando; M Sahashi; F Yamashita; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

2.  Theoretical design of prodrug-enhancer combination based on a skin diffusion model: prediction of permeation of acyclovir prodrugs treated with 1-geranylazacycloheptan-2-one.

Authors:  H Bando; T Takagi; F Yamashita; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

Review 3.  Amino Acids in the Development of Prodrugs.

Authors:  Nuno Vale; Abigail Ferreira; Joana Matos; Paula Fresco; Maria João Gouveia
Journal:  Molecules       Date:  2018-09-11       Impact factor: 4.411

4.  Bile salt-fatty acid mixed micelles as nasal absorption promoters. III. Effects on nasal transport and enzymatic degradation of acyclovir prodrugs.

Authors:  Z Shao; A K Mitra
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

Review 5.  Future of prodrugs in antiviral therapy.

Authors:  T Hasegawa; T Kawaguchi
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

6.  Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium.

Authors:  S K Jain; R K Jain; M K Chourasia; A K Jain; K B Chalasani; V Soni; A Jain
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

7.  Sustained release of acyclovir from nano-liposomes and nano-niosomes: an in vitro study.

Authors:  Biswajit Mukherjee; Balaram Patra; Buddhadev Layek; Arup Mukherjee
Journal:  Int J Nanomedicine       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.